Latest News

Yale Cancer Center and Smilow Cancer Hospital people who have been honored

Yale School of Medicine teams have received three grants totaling $18 million from Aligning Science Across Parkinson’s (ASAP), a coordinated research initiative devoted to accelerating the pace of discovery and informing the path to a cure for Parkinson’s disease (PD) research.

Seven Yale School of Medicine faculty receive Yale Faculty Innovation Awards.

Erol Fikrig, MD, is honored for his work leading to a Lyme disease vaccine, and Haifan Lin, PhD, is recognized for two "hallmark" stem cell theories.

Two Yale Cancer Center members are among six Yale researchers to receive High-Risk, High-Reward NIH grants.

Two distinguished Yale professors, Dr. Hongyu Zhao, PhD, and Dr. Mark Gerstein, PhD, have been awarded a $1.9 million grant from the National Human Genome Research Institute (NHGRI) to advance the Developmental Genotype-Tissue Expression (dGTEx) project. This landmark initiative aims to unravel the complexities of gene expression patterns across developmental stages, providing critical insights into genetic influences on health and disease.

Patho-DBiT uses DNA barcoding to map the spatial relationships of RNA and proteins, allowing for a full examination of RNA (some types have regulatory roles in cancer). The technology, created in the lab of Yale’s Rong Fan, is now licensed to Yale spin-out AtlasXomics. Dr. Fan is a member of Yale Cancer Center.

Yale researchers and scientists in 14 other countries have established a new system of dengue lineages which, they say, will allow better tracking and improve vaccine development. They recently described the new system in a study published in the journal PLOS Biology.

A new Yale Neuroscience study sheds light on how the use of alternative translation initiation sites produces multiple synaptic protein isoforms with diverse localization and functions.